miR-181a/MSC-Loaded Nano-Hydroxyapatite/Collagen Accelerated Bone Defect Repair in Rats
Author Information
Author(s): Xu Xiongjun, Feng Junming, Lin Tianze, Liu Runheng, Chen Zhuofan, Miculescu Florin, Vadgama Pankaj
Primary Institution: Hospital of Stomatology, Sun Yat-sen University, Guangzhou, China
Hypothesis
Can miR-181a overexpression in mesenchymal stem cells enhance bone defect repair by targeting the ferroptosis pathway?
Conclusion
The study shows that miR-181a/MSC-loaded nHAC scaffolds significantly enhance the repair of bone defects by promoting osteogenic differentiation and inhibiting ferroptosis.
Supporting Evidence
- miR-181a overexpression in MSCs significantly promoted osteogenic differentiation.
- miR-181a/MSC-loaded nHAC scaffolds exhibited favorable bioactivity.
- Mechanistic studies revealed that miR-181a inhibited ferroptosis by targeting the TP53/SLC7A11 pathway.
- Histological analysis showed enhanced new bone formation in the miR-181a-MSCs-nHAC group.
Takeaway
Scientists found that a special treatment using miR-181a and stem cells helped heal bone injuries in rats faster by stopping a harmful process called ferroptosis.
Methodology
Mesenchymal stem cells were isolated from human umbilical cords, transfected with miR-181a, and loaded into nano-hydroxyapatite/collagen scaffolds for in vivo testing in rat calvarial defects.
Potential Biases
Potential bias in the selection of miRNAs and the specific animal model used.
Limitations
The study was conducted only in rats, and the long-term effects of the treatment in humans are unknown.
Participant Demographics
Male Sprague–Dawley rats, aged 6–8 weeks.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website